testing by product category
biotechnology
drug discovery & development
manufactured products

home > products & services > by type > biopharmaceutical services > testing by product category

testing by product category

For easy of use, we have grouped our Biopharmaceutical Services offerings under the different category headings listed below:

Biotechnology
Drug Discovery & Development
Manufactured Products including Medical Devices

biopharmaceutical product develoment, biopharmaceutical testing services Biopharmaceutical Testing by Product Category | Charles River Charles River Biopharmaceutical Services provides clients with over twenty years of experience developing customized testing and manufacturing packages addressing the specific regulatory requirements through each step of the development of your product.

Discover the full range of Charles River Products and Services

For more information please call:

+44 (0) 1875 614545
askcharlesriver@crl.com

RELATED INFO

view all

Biopharmaceutical Services Overview

Webinar Replay: Viral Safety Assessment of Biopharmaceuticals

This webinar focused on the regulatory requirements for viral clearance studies as well as the influence of various other factors relevant to designing these studies.

Expanded Immunogenicity Testing in Biologics Now Offered

Case Study: “Challenges in the Development and Production of Live Virus Vaccines”

News & Events

view all

juil. 29 - CR and WuXi Terminate Agreement

juil. 13 - New Genetic Toxicology Assays wi...

sept. 08-sept. 11 - Kyoto, Japan - 2010 World Molecular Imaging Congress

sept. 13-sept. 15 - San Diego, CA, USA - 16th Annual Symposium on Biotechnology-Derived...

sept. 07-sept. 07 - Frankfurt, Germany - Seminar: "Immunodeficient Models"

Related Jobs

view all

Clinical Pathology Analyst Tranent, Scotl...

Health & Safety Officer Tranent, Scotland

Please have a Charles River representative contact me.

Question:

I prefer to be contacted by*phone
email
mail

*indicates a required field.

salutationfirst name*last name*titleorganization*address 1*address2city*state/province*zip/postal code*country*phone number*email address*Security Code*jbQd

The information you provided will be kept confidential.

Biopharmaceutical Services Overview

Webinar Replay: Viral Safety Assessment of Biopharmaceuticals

This webinar focused on the regulatory requirements for viral clearance studies as well as the influence of various other factors relevant to designing these studies.

Expanded Immunogenicity Testing in Biologics Now Offered

Case Study: “Challenges in the Development and Production of Live Virus Vaccines”

juil. 29

CR and WuXi Terminate Agreement

Charles River Laboratories International, Inc. (NYSE: CRL), a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech (Cayman) Inc. (NYSE: WX) to terminate their previously announced acquisition agreement. The Company also announced that its Board of Directors has authorized a new $500 million stock repurchase program.

view full story

juil. 13

New Genetic Toxicology Assays with Low Compound Requirements

Genetic toxicology testing is a key element in the development of pharmaceuticals, agrochemicals and chemicals. Formal GLP testing is required as part of the safety evaluation of all compounds; however, many companies perform non-GLP genetic toxicology screening very early to avoid expensive failures later. At this point, compound availability is normally limited, so it is important to minimize usage while ensuring the most accurate predictivity of the outcome of the eventual GLP assays. Charles River now offers in vitro genetic toxicology screening assays in which compound requirements can be as little as 10 mg: Bluescreen HC, Bluescreen HC S9 and µAmes.

view full story

sept. 08–sept. 11

2010 World Molecular Imaging Congress Kyoto, Japan

WMIC 2010 will bring attendees from different disciplines together for a comprehensive examination of the role of molecular imaging in biomedical problems. With the addition of MIR Preclinical Services, Piedmont Research Center and Cerebricon, Charles River has further expanded our discovery expertise in the key therapeutic areas of CNS, inflammation, and oncology, all complemented by cutting-edge in vivo imaging capabilities. Visit us in booth #223 to learn how our extensive service portfolio can help you with your most challenging drug development needs.

sept. 13–sept. 15

16th Annual Symposium on Biotechnology-Derived Therapeutics San Diego, CA, USA

The Biotech symposium is designed to provide insights into nonclinical development of biologics, Specific topics that will be covered include: Safety Pharmacology of Therapeutic Proteins; Impact of Immunomodulatory Agents on Host Resistance; New Paradigms for Predicting Cancer Risks Posed by Immunosuppressive Drugs; PK/PD Modeling: Extrapolating from Animal Data into First-in-Human Dose; and DART Programs for Biotherapeutics: Study Designs, Challenges and Regulatory Influences. In addition to the symposium, we will offer a workshop on endemic diseases and micro-flora as they relate to toxicology on September 12th.

sept. 07–sept. 07

Seminar: "Immunodeficient Models" Frankfurt, Germany

Charles River offers a wide range of seminars, workshops, and training courses for animal technicians, veterinarians, biologists and laboratory technicians who work with laboratory animals. For more information about our course on immunodeficient models, click "view more" below.

Clinical Pathology Analyst: Tranent, Scotland

The Clinical Pathology Analyst is responsible for undertaking routine and specialised analyses in clinical chemistry and haematology as well as for assessing and reporting clinical pathology data. Other tasks include monitoring the performance of assays and equipment with internal and external quality control, maintaining legible and permanent records of all results obtained together with relevant supporting data, and participating in development of new techniques and services.

Health & Safety Officer: Tranent, Scotland

The Health & Safety Officer provides support to the Safety Manager in all matters relating to the provision of H&S. Major responsibilities of this position include: providing assistance to local managers with assessments and other practical requirements as necessary under H&S legislation; assisting in the operation, development and organisation of safety and health monitoring schemes; assisting in the development and monitoring of systems for the control of all operations involving the use of radioactive materials in accordance with current legislation; undertaking incident investigations as necessary; serving as a liaison with the Occupation Health Service and internal and external Enforcing Authorities as required; carrying out regular H&S audits; and assisting in staff safety training.

Charles River Laboratories, Inc.